Quick Answer Adeia Inc. reported Cash and Equivalents of $73.14 million for fiscal year 2025. Adeia Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $73.14M -7.2% 2024 $78.83M +44.5% 2023 $54.56M -52.4% 2022 $114.56M +42.4% 2021 $80.43M -52.7% 2020 $170.19M +128.3% 2019 $74.55M — Quarterly Cash and Equivalents … Read more
Quick Answer Adeia Inc. reported Total Assets of $1.04 billion for fiscal year 2025. Adeia Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $1.04B -5.3% 2024 $1.10B -0.7% 2023 $1.11B -8.7% 2022 $1.21B -51.0% 2021 $2.47B -8.6% 2020 $2.70B +157.8% 2019 $1.05B — Quarterly Total Assets Quarter Ending Total Assets … Read more
Quick Answer Adeia Inc. reported Net Income of $64.62 million for fiscal year 2024. Adeia Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2024 $64.62M -4.1% 2023 $67.37M +122.8% 2022 -$295.88M -433.5% 2021 -$55.46M -137.8% 2020 $146.76M +334.7% 2019 -$62.53M -21536.7% 2018 -$289.0K — Quarterly Net Income Quarter Ending Net Income … Read more
Quick Answer Adeia Inc. reported Diluted EPS of $0.99 per share for fiscal year 2025. Adeia Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $0.99 +73.7% 2024 $0.57 -5.0% 2023 $0.60 +121.8% 2022 -$2.75 -428.8% 2021 -$0.52 -129.7% 2020 $1.75 +237.8% 2019 -$1.27 -12600.0% 2018 -$0.01 — Quarterly Diluted EPS … Read more
Quick Answer Adeia Inc. reported Revenue (ASC 606) of $443.39 million for fiscal year 2025. Adeia Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $443.39M +17.9% 2024 $376.02M -3.3% 2023 $388.79M -11.4% 2022 $438.93M +12.2% 2021 $391.21M -24.2% 2020 $515.92M +84.2% 2019 $280.07M -31.0% 2018 $406.13M — Quarterly … Read more
Quick Answer Adeia Inc. reported Total Revenue of $443.39 million for fiscal year 2025. Adeia Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $443.39M +17.9% 2024 $376.02M -3.3% 2023 $388.79M -11.4% 2022 $438.93M +12.2% 2021 $391.21M -24.2% 2020 $515.92M +84.2% 2019 $280.07M -31.0% 2018 $406.13M — Quarterly Total Revenue Quarter … Read more
Quick Answer Adeia Inc. reported Total Revenue of $443.39 million for fiscal year 2025. Adeia Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $443.39M+17.9% $376.02M-3.3% $388.79M-11.4% $438.93M+12.2% $391.21M-24.2% $515.92M+84.2% Revenue (ASC 606) $443.39M+17.9% $376.02M-3.3% $388.79M-11.4% $438.93M+12.2% $391.21M-24.2% $515.92M+84.2% Net Income — $64.62M-4.1% $67.37M+122.8% -$295.88M-433.5% -$55.46M-137.8% $146.76M+334.7% Diluted EPS … Read more
Quick Answer ADC Therapeutics SA reported Shares Outstanding of 125.75 million shares for fiscal year 2025. ADC Therapeutics SA Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 125.75M +27.2% 2024 98.86M +20.1% 2023 82.29M +2.0% 2022 80.64M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 112.63M … Read more
Quick Answer ADC Therapeutics SA reported Operating Income of -$121.50 million for fiscal year 2025. ADC Therapeutics SA Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$121.50M +7.0% 2024 -$130.65M +21.3% 2023 -$165.99M -34.6% 2022 -$123.34M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$30.97M +12.9% … Read more
Quick Answer ADC Therapeutics SA reported R&D Expense of $104.00 million for fiscal year 2025. ADC Therapeutics SA R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $104.00M -5.1% 2024 $109.63M -13.8% 2023 $127.13M -31.8% 2022 $186.46M +18.0% 2021 $158.00M +11.2% 2020 $142.03M +32.1% 2019 $107.54M -9.1% 2018 $118.31M — Quarterly R&D … Read more